World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
23935
World Ranking
12376
National Ranking
6336

Overview

Ara A. Vaporciyan is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans various areas within medicine, with a strong focus on pulmonary and respiratory medicine, oncology, surgery, radiology, nuclear medicine, imaging, and cancer research.

Their work predominantly revolves around lung cancer diagnosis and treatment, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, cancer genomics and diagnostics, radiomics and machine learning in medical imaging, gastric cancer management and outcomes, as well as esophageal cancer research and treatment.

Frequent coauthors in their publications include Mara B. Antonoff, Boris Sepesi, Stephen G. Swisher, John V. Heymach, and Reza J. Mehran, indicating collaborations with experts in related fields.

They have published extensively in several journals and conferences, with frequent publication venues including:

  • Journal of Thoracic and Cardiovascular Surgery
  • The Annals of Thoracic Surgery
  • Journal of Thoracic Oncology
  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology

Notable recent papers include:

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, Nature Medicine
  • Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery, 2021, The Lancet Oncology
  • Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer, 2020, Journal of Clinical Oncology
  • Comprehensive T cell repertoire characterization of non-small cell lung cancer, 2020, Nature Communications
  • Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial, 2023, The Lancet

Best Publications

  • Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo

    Ara A. Vaporciyan;Horace M. DeLisser;Horng Chin Yan;Ignacio I. Mendiguren

  • C5a-induced expression of P-selectin in endothelial cells.

    Kimberly E. Foreman;Ara A. Vaporciyan;Brian K. Bonish;Michael L. Jones

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

    Tina Cascone;William N. William;Annikka Weissferdt;Cheuk H. Leung

  • Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients

    Ara A Vaporciyan;Arlene M Correa;David C Rice;Jack A Roth

  • Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

    Stephen G. Swisher;Mary Maish;Jeremy J. Erasmus;Arlene M. Correa

  • Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.

    Apar Pataer;Neda Kalhor;Arlene M. Correa;Maria Gabriela Raso

  • 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.

    Stephen G. Swisher;Jeremy Erasmus;Mary Maish;Arlene M. Correa

  • Treatment Outcomes of Resected Esophageal Cancer

    Wayne Hofstetter;Stephen G. Swisher;Arlene M. Correa;Kenneth Hess

  • Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy

    Stephen G. Swisher;Paula Wynn;Joe B. Putnam;Melinda B. Mosheim

  • Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

    Charles S. Cleeland;Xin Shelley Wang;Qiuling Shi;Tito R. Mendoza

  • Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

    Stephen G Swisher;Jack A Roth;Ritsuko Komaki;Jian Gu

  • Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

    Zhongxing Liao;J. Jack Lee;Ritsuko Komaki;Daniel R. Gomez

  • Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter

    Joe B. Putnam;Garrett L. Walsh;Stephen G. Swisher;Jack A. Roth

  • Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1

    Michael S. Mulligan;Ara A. Vaporciyan;Masayuki Miyasaka;Takuya Tamatani

  • Management of primary pulmonary artery sarcomas.

    Shanda H. Blackmon;David C Rice;Arlene M Correa;Reza John Mehran

  • Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

    Shu Lian Wang;Zhongxing Liao;Ara A Vaporciyan;Susan L. Tucker

  • Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

    David C. Rice;Craig W. Stevens;Arlene M. Correa;Ara A. Vaporciyan

  • Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.

    Joe Y Chang;Reza J Mehran;Lei Feng;Vivek Verma

  • Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.

    Hoon K Lee;Ara A Vaporciyan;James D Cox;Susan L Tucker

  • Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents.

    Ara A. Vaporciyan;Carolyn E. Reed;Clese Erikson;Michael J. Dill

Frequent Co-Authors

Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Garrett L. Walsh
Garrett L. Walsh The University of Texas MD Anderson Cancer Center
Wayne L. Hofstetter
Wayne L. Hofstetter The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Joe B. Putnam
Joe B. Putnam The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing medicine in the USA can open doors to a wide range of health-related careers. Increasingly, students are exploring flexible and online degree options to expand their qualifications or specialize in key areas. For example, you can gain expertise in personal and public health by completing one of the best online nutrition programs, which prepare graduates for rewarding roles in dietetics and wellness.

Those interested in healthcare management may consider the top online mha programs that are cahme accredited, ensuring a recognized and high-quality education for future leaders. Registered nurses looking to advance can explore rn to bsn no clinical hours programs that offer academic advancement without the additional clinical requirements.

Finally, seasoned nurses with a master’s degree can reach the pinnacle of clinical practice more quickly with the shortest post master's dnp program options. Exploring these related degrees expands your career pathways in healthcare, no matter your stage or specialty.

Best Scientists Citing Ara A. Vaporciyan

Trending Scientists